Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705

Watchlist Manager
Hunan Jiudian Pharmaceutical Co Ltd Logo
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Watchlist
Price: 23.8 CNY 2.15% Market Closed
Market Cap: 11.7B CNY
Have any thoughts about
Hunan Jiudian Pharmaceutical Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

20.3
Current
20.4
Median
16.6
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
20.3
=
Enterprise Value
11.4B CNY
/
EBIT
559.3m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
19.8
2-Years Forward
EV/EBIT
15
3-Years Forward
EV/EBIT
11.8

See Also

Discover More